Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives
PlexusDx's compounded semaglutide from licensed 503A pharmacies allows flexible dosing modifications that mass-produced versions cannot offer
GLUTATHIONE is the master antioxidant that counteracts free radicals, boosts the immune system and detoxifies the liver
Retrieved April 1, 2024, from QOL Medical, LLC
US$ 28.70
US$ 21.37
US$ 21.66
